Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.

BioMed Central, Allergy, Asthma and Clinical Immunology, 1(13), 2017

Journal article published in 2017 by M. Wiednig, L. Martin, Werner Aberer, A. Masseau, Y. Ollivier, A. Sobel, I. Martinez-Saguer, E. Papadopoulou-Alataki, F. Psarros, A. Reshef, E. Toubi, Marcus Maurer, , Montinaro, L. Marques and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by